HomeCompareSLRK vs MRK

SLRK vs MRK: Dividend Comparison 2026

SLRK yields 11.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $15.3K in total portfolio value· pulled ahead in Year 8
10 years
SLRK
SLRK
● Live price
11.05%
Share price
$18.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.5K
Annual income
$2,207.02
Full SLRK calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SLRK vs MRK

📍 MRK pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLRKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLRK + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLRK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLRK
Annual income on $10K today (after 15% tax)
$939.23/yr
After 10yr DRIP, annual income (after tax)
$1,875.97/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $6,452.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLRK + MRK for your $10,000?

SLRK: 50%MRK: 50%
100% MRK50/50100% SLRK
Portfolio after 10yr
$49.1K
Annual income
$6,002.58/yr
Blended yield
12.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SLRK
No analyst data
Altman Z
0.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLRK buys
0
MRK buys
0
No recent congressional trades found for SLRK or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLRKMRK
Forward yield11.05%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$41.5K$56.8K
Annual income after 10y$2,207.02$9,798.13
Total dividends collected$16.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SLRK vs MRK ($10,000, DRIP)

YearSLRK PortfolioSLRK Income/yrMRK PortfolioMRK Income/yrGap
1$11,805$1,104.97$11,206$366.19+$599.00SLRK
2$13,850$1,219.08$12,650$502.35+$1.2KSLRK
3$16,157$1,336.74$14,407$694.19+$1.8KSLRK
4$18,745$1,457.31$16,585$967.82+$2.2KSLRK
5$21,637$1,580.16$19,342$1,363.89+$2.3KSLRK
6$24,857$1,704.65$22,913$1,947.19+$1.9KSLRK
7$28,427$1,830.16$27,662$2,823.89+$765.00SLRK
8← crossover$32,373$1,956.10$34,159$4,173.35$1.8KMRK
9$36,721$2,081.89$43,337$6,308.80$6.6KMRK
10$41,498$2,207.02$56,776$9,798.13$15.3KMRK

SLRK vs MRK: Complete Analysis 2026

SLRKStock

Solera National Bancorp, Inc. operates as the bank holding company for Solera National Bank that provides commercial and consumer banking services to small and medium-sized businesses, licensed professionals, and individuals in the United States. The company offers deposit products, including checking and savings accounts, money market accounts, time and demand deposits, and certificates of deposit; and business loan products, such as real estate secured loans, construction loans, small business administration loans, business lines of credit, and equipment financing. It also provides online banking, account analysis, combined account analysis, commercial sweep, remote deposit, ACH origination, payroll direct deposit, merchant, fraud, business debit card, and cash management services. In addition, the company offers self-directed checking accounts and non-resource financing. The company was founded in 2005 and is headquartered in Lakewood, Colorado.

Full SLRK Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SLRK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLRK vs SCHDSLRK vs JEPISLRK vs OSLRK vs KOSLRK vs MAINSLRK vs JNJSLRK vs ABBVSLRK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.